Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2025-12-25 @ 12:01 PM
NCT ID: NCT03359161
Description: None
Frequency Threshold: 0
Time Frame: 30 days
Study: NCT03359161
Study Brief: Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
In-Home Subcutaneous Furosemide Treatment ARm Prospective, open-label arm to evaluate the clinical effectiveness of a novel formulation of furosemide delivered by subcutaneous administration. sc2Wear Furosemide Infusor: Subcutaneous furosemide for the treatment of fluid overload 0 None 0 9 0 9 View
Serious Events(If Any):
Other Events(If Any):